Biological functions
| Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
|---|---|---|---|---|---|---|---|---|---|---|
| KEGG | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 86/6848 | 89/8135 | 0.0001894 | 0.0008325 | 0.0003568 | 86 | RABC28 | |
| KEGG | hsa05225 | Hepatocellular carcinoma | 157/6848 | 168/8135 | 0.0002084 | 0.000904 | 0.0003875 | 157 | RABC28 | |
| KEGG | hsa04540 | Gap junction | 85/6848 | 88/8135 | 0.0002183 | 0.0009347 | 0.0004006 | 85 | RABC28 | |
| KEGG | hsa04066 | HIF-1 signaling pathway | 104/6848 | 109/8135 | 0.0002358 | 0.0009969 | 0.0004273 | 104 | RABC28 | |
| KEGG | hsa00280 | Valine, leucine and isoleucine degradation | 48/6848 | 48/8135 | 0.0002503 | 0.001034 | 0.0004433 | 48 | RABC28 | |
| KEGG | hsa01522 | Endocrine resistance | 94/6848 | 98/8135 | 0.0002508 | 0.001034 | 0.0004433 | 94 | RABC28 | |
| KEGG | hsa04918 | Thyroid hormone synthesis | 73/6848 | 75/8135 | 0.0002657 | 0.001082 | 0.0004638 | 73 | RABC28 | |
| KEGG | hsa04911 | Insulin secretion | 83/6848 | 86/8135 | 0.0002895 | 0.001165 | 0.0004994 | 83 | RABC28 | |
| KEGG | hsa00561 | Glycerolipid metabolism | 60/6848 | 61/8135 | 0.0003298 | 0.00131 | 0.0005613 | 60 | RABC28 | |
| KEGG | hsa04012 | ErbB signaling pathway | 82/6848 | 85/8135 | 0.0003333 | 0.00131 | 0.0005613 | 82 | RABC28 | |
| KEGG | hsa04928 | Parathyroid hormone synthesis, secretion and action | 101/6848 | 106/8135 | 0.0003477 | 0.00135 | 0.0005788 | 101 | RABC28 | |
| KEGG | hsa00562 | Inositol phosphate metabolism | 71/6848 | 73/8135 | 0.0003575 | 0.001372 | 0.0005882 | 71 | RABC28 | |
| KEGG | hsa05016 | Huntington disease | 278/6848 | 306/8135 | 0.0003728 | 0.001415 | 0.0006065 | 278 | RABC28 | |
| KEGG | hsa05010 | Alzheimer disease | 346/6848 | 384/8135 | 0.0003994 | 0.001499 | 0.0006425 | 346 | RABC28 | |
| KEGG | hsa05130 | Pathogenic Escherichia coli infection | 182/6848 | 197/8135 | 0.0004141 | 0.001505 | 0.0006451 | 182 | RABC28 | |
| KEGG | hsa05218 | Melanoma | 70/6848 | 72/8135 | 0.0004145 | 0.001505 | 0.0006451 | 70 | RABC28 | |
| KEGG | hsa04270 | Vascular smooth muscle contraction | 126/6848 | 134/8135 | 0.0004146 | 0.001505 | 0.0006451 | 126 | RABC28 | |
| KEGG | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 134/6848 | 143/8135 | 0.0004326 | 0.001554 | 0.000666 | 134 | RABC28 | |
| KEGG | hsa04625 | C-type lectin receptor signaling pathway | 99/6848 | 104/8135 | 0.0004495 | 0.001583 | 0.0006785 | 99 | RABC28 | |
| KEGG | hsa04724 | Glutamatergic synapse | 108/6848 | 114/8135 | 0.0004503 | 0.001583 | 0.0006785 | 108 | RABC28 | |
| KEGG | hsa04520 | Adherens junction | 69/6848 | 71/8135 | 0.0004803 | 0.001671 | 0.0007163 | 69 | RABC28 | |
| KEGG | hsa04962 | Vasopressin-regulated water reabsorption | 44/6848 | 44/8135 | 0.0005007 | 0.001724 | 0.0007389 | 44 | RABC28 | |
| KEGG | hsa05014 | Amyotrophic lateral sclerosis | 328/6848 | 364/8135 | 0.0005587 | 0.001904 | 0.0008162 | 328 | RABC28 | |
| KEGG | hsa05031 | Amphetamine addiction | 67/6848 | 69/8135 | 0.0006445 | 0.002153 | 0.0009226 | 67 | RABC28 | |
| KEGG | hsa05211 | Renal cell carcinoma | 67/6848 | 69/8135 | 0.0006445 | 0.002153 | 0.0009226 | 67 | RABC28 | |
| KEGG | hsa04723 | Retrograde endocannabinoid signaling | 138/6848 | 148/8135 | 0.0006853 | 0.002266 | 0.0009713 | 138 | RABC28 | |
| KEGG | hsa05417 | Lipid and atherosclerosis | 197/6848 | 215/8135 | 0.0008414 | 0.002755 | 0.001181 | 197 | RABC28 | |
| KEGG | hsa04512 | ECM-receptor interaction | 84/6848 | 88/8135 | 0.0009477 | 0.003055 | 0.00131 | 84 | RABC28 | |
| KEGG | hsa04750 | Inflammatory mediator regulation of TRP channels | 93/6848 | 98/8135 | 0.0009605 | 0.003055 | 0.00131 | 93 | RABC28 | |
| KEGG | hsa05231 | Choline metabolism in cancer | 93/6848 | 98/8135 | 0.0009605 | 0.003055 | 0.00131 | 93 | RABC28 |